Biblio

Didier A., Millo J., Marechal B., Rocher C., Lacroute C., Ouisse M., Rubiola E., Kersale Y..  2017.  Compact Ultra-Stable Laser. 2017 JOINT CONFERENCE OF THE EUROPEAN FREQUENCY AND TIME FORUM AND IEEE INTERNATIONAL FREQUENCY CONTROL SYMPOSIUM (EFTF/IFC). :775-776.

Lacroute C, Souidi M, Bourgeois P-Y, Millo J, Saleh K, Bigler E, Boudot R, Giordano V, Kersale Y.  2016.  Compact Yb+ optical atomic clock project: design principle and current status. 8TH SYMPOSIUM ON FREQUENCY STANDARDS AND METROLOGY 2015. 723:012025.

Mokhtar-Kharroubi M.  2016.  COMPACTNESS PROPERTIES OF PERTURBED SUB -STOCHASTIC C-0-SEMIGROUPS ON L-1 (mu) WITH APPLICATIONS TO DISCRETENESS AND SPECTRAL GAPS INTRODUCTION. COMPACTNESS PROPERTIES OF PERTURBED SUB-STOCHASTIC C0-SEMIGROUPS ON L1(MU) WITH APPLICATIONS TO DISCRETENESS AND SPECTRAL GAPS. 148:1+.

Mokhtar-Kharroubi M.  2016.  COMPACTNESS RESULTS ON ABSTRACT L-1(Omega: A, mu) SPACES. COMPACTNESS PROPERTIES OF PERTURBED SUB-STOCHASTIC C0-SEMIGROUPS ON L1(MU) WITH APPLICATIONS TO DISCRETENESS AND SPECTRAL GAPS. 148:31-36.

Mokhtar-Kharroubi M.  2016.  COMPACTNESS RESULTS ON L-1 (Omega; d, mu). COMPACTNESS PROPERTIES OF PERTURBED SUB-STOCHASTIC C0-SEMIGROUPS ON L1(MU) WITH APPLICATIONS TO DISCRETENESS AND SPECTRAL GAPS. 148:43-48.

Daussy H.  2014.  A Companion to Reformed Orthodoxy.. RENAISSANCE AND REFORMATION. 37:177-179.

Daussy H.  2018.  A Companion to the Reformation in Central Europe. RENAISSANCE AND REFORMATION. 41:245-247.

Gourgues G, Sainty J.  2015.  Company Negotiation in the Referendum Trap. Lessons from the New Company Agreements in Fiat's Italian Factories (2010-2011). SOCIOLOGIE DU TRAVAIL. 57:344-368.

Beal S, Deschamps M, Solal P.  2016.  COMPARABLE AXIOMATIZATIONS OF TWO ALLOCATION RULES FOR COOPERATIVE GAMES WITH TRANSFERABLE UTILITY AND THEIR SUBCLASS OF DATA GAMES. JOURNAL OF PUBLIC ECONOMIC THEORY. 18:992-1004.

Ellouze O, Vuillet M, Perrot J, Grosjean S, Missaoui A, Aho S, Malapert G, Bouhemad B, Bouchot O, Girard C.  2018.  Comparable Outcome of Out-of-Hospital Cardiac Arrest and In-Hospital Cardiac Arrest Treated With Extracorporeal Life Support. ARTIFICIAL ORGANS. 42:15-21.

Shimoni A, Labopin M, Savani BN, Hamladji R-M, Beelen DW, Mufti GJ, Socie G, Delage J, Blaise D, Chevallier P et al..  2016.  Comparable Outcomes after Allogeneic Stem-Cell Transplantation with Intravenous Busulfan or Treosulfan-Based Reduced-Intensity and Reduced Toxicity Regimens in Acute Myeloid Leukemia. a Study on Behalf of the Acute Leukemia Working Party of EBMT. BLOOD. 128

Bazarbachi A, Labopin M, Blaise D, Forcade E, Socie G, Berceanu A, Bulabois CEric, Kroger N, Rambaldi A, Ceballos P et al..  2020.  Comparable Outcomes of AML Patients Receiving Haplo-HCT with Thiotepa/Busulfan/Fludarabine Conditioning and Post-Transplant Cyclophosphamide Versus a Matched Unrelated Donor with Fludarabine/Busulfan Conditioning, Regardless of Disease Status. BONE MARROW TRANSPLANTATION. 55:23-24.

Bazarbachi A, Labopin M, Blaise D, Forcade E, Socie G, Berceanu A, Bulabois CEric, Kroger N, Rambaldi A, Ceballos P et al..  2020.  Comparable Outcomes of AML Patients Receiving Haplo-HCT with Thiotepa/Busulfan/Fludarabine Conditioning and Post-Transplant Cyclophosphamide Versus a Matched Unrelated Donor with Fludarabine/Busulfan Conditioning, Regardless of Disease Status. BONE MARROW TRANSPLANTATION. 55:23-24.

T. Rao R, Mahapatra S., Honvault P..  2014.  A comparative account of quantum dynamics of the H+ + H-2 reaction at low temperature on two different potential energy surfaces. JOURNAL OF CHEMICAL PHYSICS. 141:064306.

Beber CLuiz, Couto Rda Rosa, Lovato PEmilio, Guillemin J-P, Nicolardot B, Schenato RBergamo, Comin JJose.  2018.  Comparative agroenvironmental risks of pesticides in different cropping systems: application of the I-Phy indicator. ENVIRONMENTAL EARTH SCIENCES. 77:532.

Gruel Y, Vayne C, Rollin J, Weber P, Faille D, Bauters A, Macchi L, Alhenc-Gelas M, Lebreton A, De Maistre E et al..  2020.  Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature. THROMBOSIS AND HAEMOSTASIS. 120:1096-1107.

Gusmano M, Rodwin VG, Weisz D, Cottenet J, Quantin C.  2016.  A Comparative Analysis of Hospital Readmissions in France and the US. JOURNAL OF COMPARATIVE POLICY ANALYSIS. 18:195-209.

Chin N., Paraskeva M., Paul E., Cantwell L., Levvey B., Williams T., Snell G., Westall G..  2015.  Comparative analysis of how immune sensitization is defined prior to lung transplantation. HUMAN IMMUNOLOGY. 76:711-716.

Biancari F, Ruggieri VG, Perrotti A, Gherli R, Demal T, Franzese I, Dalen M, Santarpino G, Rubino AS, Maselli D et al..  2019.  Comparative Analysis of Prothrombin Complex Concentrate and Fresh Frozen Plasma in Coronary Surgery. HEART LUNG AND CIRCULATION. 28:1881-1887.

Deroh M., Beugnot J-C, Hammani K., Finot C., Fatome J., Smektala F., Maillotte H., Sylvestre T., Kibler B..  2020.  Comparative analysis of stimulated Brillouin scattering at 2 mu m in various infrared glass-based optical fibers. JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS. 37:3792-3800.

Bouzid I, Maire J, Fatin-Rouge N.  2019.  Comparative assessment of a foam-based method for ISCO of coal tar contaminated unsaturated soils. JOURNAL OF ENVIRONMENTAL CHEMICAL ENGINEERING. 7:103346.

Bouzid I, Maire J, Fatin-Rouge N.  2019.  Comparative assessment of a foam-based oxidative treatment of hydrocarbon-contaminated unsaturated and anisotropic soils. CHEMOSPHERE. 233:667-676.

Peterse EFP, Osoro CB, Bardou M, Lansdorp-Vogelaar I.  2021.  Comparative benefit and cost-effectiveness of mailed-out faecal immunochemical tests vs collection at the general practitioner. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 53:1118-1125.

Guillaume YClaude, Andre C.  2017.  Comparative binding to DR4 and DR5 receptors of TRAIL and BNNTs/PAHE/mPEG-DSPE/TRAIL nanoparticles. JOURNAL OF MOLECULAR RECOGNITION. 30:e2611.

Comi G., Boster A., Alroughani R., Berkovich R., Izquierdo G., Kantor D., Laganke C., Limmroth V., Macdonell R., Moreau T. et al..  2017.  Comparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses. EUROPEAN JOURNAL OF NEUROLOGY. 24:492.